08 Nov The KDM6A/B inhibition affects viability of SMARCB1 deficient tumors through the disruption of autophagy and angiogenesis in pediatric cancer.

ID: 2656

Autores: Romero-Ferraro, Octavio (0); Vilarrubí , Andrea (1); Navajas, Pablo  (1); Morillas, Juan M (1); Díaz, Ana Cristina (1); Pros, Eva  (1); Martín, Gabriela (3); Roué, Gaël  (1); Martinez, Anabel  (1); Castillo , Sandra  (1); Graupera, Mariona  (1); Carretero, Julian  (4); Villanueva, Alberto  (2); Sánchez, Montse (1); Romero, Octavio (1)

Temática: New frontiers in treatment/Precision medicine